Skip to main content
Top
Published in: Pediatric Cardiology 2/2023

Open Access 16-11-2022 | Atorvastatin | Research

Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms

Authors: Bruke A. Tedla, Jane C. Burns, Adrianna H. Tremoulet, Chisato Shimizu, John B. Gordon, Howaida El-Said, Fraser Golding, Christopher K. Davis, Kirsten B. Dummer

Published in: Pediatric Cardiology | Issue 2/2023

Login to get access

Abstract

The most significant sequelae of Kawasaki disease (KD) are coronary artery aneurysms, which can lead to risk of future myocardial ischemia. Exercise stress echocardiography allows for non-invasive assessment of myocardial dysfunction. We reviewed our single center experience with exercise stress echocardiography in patients with previous history of KD with coronary aneurysms. We reviewed the records of 53 KD patients who underwent exercise stress echocardiography from 2000 to 2020. Abnormal stress echocardiograms were defined as those showing no increase in biventricular systolic function post-exercise or regional wall motion abnormalities. Computed tomography angiography and cardiac magnetic resonance imaging were reviewed for patients with abnormal stress echocardiograms. Clinical data were reviewed and correlated with stress echocardiogram results. Of the 53 patients, three (5.7%) had an abnormal exercise stress echocardiogram. All three patients were classified as AHA Risk Level 4 or 5 by coronary Z-score (internal dimension normalized for body surface area) and were confirmed to have coronary aneurysms, stenosis, or myocardial tissue perfusion defects on advanced cardiac imaging that could account for the results seen on stress echocardiogram. Exercise stress echocardiography detected signs of myocardial ischemia in a subset of high-risk patients with Kawasaki disease and coronary aneurysms and may be considered as a useful screening tool for this complex patient cohort.
Literature
12.
17.
go back to reference Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, Printz B, Dominguez SR, Heizer H, Anderson MS, Glodé MP, He F, Padilla RL, Shimizu C, Bainto E, Pancheri J, Cohen HJ, Whitin JC, Burns JC (2019) Phase I/IIa trial of atorvastatin in patients with acute kawasaki disease with coronary artery aneurysm. J Pediatr 215:107-117.e12. https://doi.org/10.1016/j.jpeds.2019.07.064CrossRef Tremoulet AH, Jain S, Jone PN, Best BM, Duxbury EH, Franco A, Printz B, Dominguez SR, Heizer H, Anderson MS, Glodé MP, He F, Padilla RL, Shimizu C, Bainto E, Pancheri J, Cohen HJ, Whitin JC, Burns JC (2019) Phase I/IIa trial of atorvastatin in patients with acute kawasaki disease with coronary artery aneurysm. J Pediatr 215:107-117.e12. https://​doi.​org/​10.​1016/​j.​jpeds.​2019.​07.​064CrossRef
Metadata
Title
Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms
Authors
Bruke A. Tedla
Jane C. Burns
Adrianna H. Tremoulet
Chisato Shimizu
John B. Gordon
Howaida El-Said
Fraser Golding
Christopher K. Davis
Kirsten B. Dummer
Publication date
16-11-2022
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 2/2023
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-022-03037-1

Other articles of this Issue 2/2023

Pediatric Cardiology 2/2023 Go to the issue